Completed PHASE4 INTERVENTIONAL 1-arm NCT00737464

A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once-monthly Administration of Intravenous MIRCERA for the Maintenance of Haemoglobin Levels in Dialysis Patients With Chronic Renal Anaemia

Sponsor: Hoffmann-La Roche

Conditions Anemia

Interventions methoxy polyethylene glycol-epoetin beta [Mircera]

Updated 6 times since 2017 Last updated: Nov 2, 2017 Started: Aug 26, 2008 Primary completion: Sep 12, 2009 Completion: Sep 12, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Anemia, this trial is completed. The trial is conducted by Hoffmann-La Roche and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Aug 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Completed PHASE4

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hoffmann-La Roche

Data source: Hoffmann-La Roche

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bangalore, India , Chennai, India , Guwahati, India , Hyderabad, India , Kanpur, India , Kolkata, India , Meerut, India , Mohali, India , Mumbai, India , New Delhi, India and 1 more location